PRESS RELEASE published on 01/20/2025 at 10:56, 1 year 4 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% du capital de KERING par Citigroup Inc. le 13 janvier 2025. Détention de 6 597 789 actions KERING, soit 5,35% du capital et 3,73% des droits de vote Déclaration Droits De Vote Franchissement De Seuil Citigroup Inc. Kering
BRIEF published on 01/16/2025 at 18:32, 1 year 4 months ago Kering Reports Shares and Voting Rights as of January 2025 Voting Rights Shares AMF Regulation Kering January 2025
BRIEF published on 01/16/2025 at 18:32, 1 year 4 months ago Kering publie son nombre d'actions et de droits de vote au 31 janvier 2025 Actions Règlement AMF Droit De Vote Kering Janvier 2025
PRESS RELEASE published on 01/16/2025 at 18:27, 1 year 4 months ago Kering: Monthly statement on the total number of shares and voting rights (January 2025) Kering's monthly statement on total shares and voting rights as of January 15, 2025. Total shares: 123,420,778. Total voting rights: 176,704,149 (theoretical) and 175,885,064 (exercisable) Voting Rights Shares AMF Kering January 15 2025
PRESS RELEASE published on 01/16/2025 at 18:27, 1 year 4 months ago Kering : Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote (Janvier 2025) Publication mensuelle du nombre d’actions et de droits de vote pour Kering. Détails au 15/01/2025 Capital Droits De Vote Actions AMF Kering
BRIEF published on 12/16/2024 at 12:12, 1 year 5 months ago Kering Releases December 2024 Share and Voting Rights Statement Voting Rights Shares AMF Kering December 2024
BRIEF published on 12/16/2024 at 12:12, 1 year 5 months ago Kering publie sa déclaration d'actions et de droits de vote pour décembre 2024 Actions AMF Droit De Vote Kering Décembre 2024
PRESS RELEASE published on 12/16/2024 at 12:07, 1 year 5 months ago Kering: Monthly statement on the total number of shares and voting rights (December 2024) Kering provides a monthly statement on total shares and voting rights. Details include 123,420,778 shares and 175,888,233 exercisable voting rights as of December 13, 2024 Voting Rights Shares Financial Disclosure Monthly Statement Kering
PRESS RELEASE published on 12/16/2024 at 12:07, 1 year 5 months ago Kering : Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote (Décembre 2024) Kering publie le nombre d'actions et de droits de vote en circulation en décembre 2024 conformément aux réglementations en vigueur Capital Droits De Vote Actions AMF Kering
BRIEF published on 11/19/2024 at 11:13, 1 year 6 months ago Publication de Kering : Actions et Droits de Vote - Novembre 2024 Droits De Vote Actions AMF Kering Novembre 2024
Published on 05/23/2026 at 03:15, 10 hours 14 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 10 hours 29 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 11 hours 4 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 11 hours 4 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 12 hours 29 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/22/2026 at 22:05, 15 hours 24 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 15 hours 24 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 17 hours 38 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 18 hours 56 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 18 hours 59 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 17 hours 54 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 19 hours 24 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 19 hours 24 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
